These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 15049988)

  • 21. The overactive bladder: review of current pharmacotherapy in adults. Part 2: treatment options in cases refractory to anticholinergics.
    Sahai A; Khan MS; Arya M; John J; Singh R; Patel HR
    Expert Opin Pharmacother; 2006 Apr; 7(5):529-38. PubMed ID: 16553568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VEGF signaling mediates bladder neuroplasticity and inflammation in response to BCG.
    Saban MR; Davis CA; Avelino A; Cruz F; Maier J; Bjorling DE; Sferra TJ; Hurst RE; Saban R
    BMC Physiol; 2011 Nov; 11():16. PubMed ID: 22059553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute Intravesical Capsaicin for the Study of TRPV1 in the Lower Urinary Tract: Clinical Relevance and Potential for Innovation.
    Andersson KE; Behr-Roussel D; Denys P; Giuliano F
    Med Sci (Basel); 2022 Sep; 10(3):. PubMed ID: 36135835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrathecal delivery of resiniferatoxin (RTX) reduces detrusor overactivity and spinal expression of TRPV1 in spinal cord injured animals.
    Cruz CD; Charrua A; Vieira E; Valente J; Avelino A; Cruz F
    Exp Neurol; 2008 Dec; 214(2):301-8. PubMed ID: 18824169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: a double-blind, randomized, controlled study.
    de Sèze M; Wiart L; de Sèze MP; Soyeur L; Dosque JP; Blajezewski S; Moore N; Brochet B; Mazaux JM; Barat M; Joseph PA
    J Urol; 2004 Jan; 171(1):251-5. PubMed ID: 14665887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Up-regulation of brain-derived neurotrophic factor in primary afferent pathway regulates colon-to-bladder cross-sensitization in rat.
    Xia CM; Gulick MA; Yu SJ; Grider JR; Murthy KS; Kuemmerle JF; Akbarali HI; Qiao LY
    J Neuroinflammation; 2012 Feb; 9():30. PubMed ID: 22335898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial.
    Cruz F; Herschorn S; Aliotta P; Brin M; Thompson C; Lam W; Daniell G; Heesakkers J; Haag-Molkenteller C
    Eur Urol; 2011 Oct; 60(4):742-50. PubMed ID: 21798658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravesical resiniferatoxin for the treatment of detrusor hyperreflexia refractory to capsaicin in patients with chronic spinal cord diseases.
    Lazzeri M; Spinelli M; Beneforti P; Zanollo A; Turini D
    Scand J Urol Nephrol; 1998 Sep; 32(5):331-4. PubMed ID: 9825395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autonomous contractile activity in the isolated rat bladder is modulated by a TRPV1 dependent mechanism.
    Gevaert T; Vandepitte J; Ost D; Nilius B; De Ridder D
    Neurourol Urodyn; 2007; 26(3):424-32; discussion 451-3. PubMed ID: 17004230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of intravesical capsaicin on the suburothelial innervation in patients with detrusor hyper-reflexia.
    Dasgupta P; Chandiramani VA; Beckett A; Scaravilli F; Fowler CJ
    BJU Int; 2000 Feb; 85(3):238-45. PubMed ID: 10671875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased severity of inflammation correlates with elevated expression of TRPV1 nerve fibers and nerve growth factor on interstitial cystitis/bladder pain syndrome.
    Liu BL; Yang F; Zhan HL; Feng ZY; Zhang ZG; Li WB; Zhou XF
    Urol Int; 2014; 92(2):202-8. PubMed ID: 24458144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Refractory neurogenic detrusor overactivity.
    Cruz F; Silva C
    Int J Clin Pract Suppl; 2006 Dec; (151):22-6. PubMed ID: 17169007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rat detrusor overactivity induced by chronic spinalization can be abolished by a transient receptor potential vanilloid 1 (TRPV1) antagonist.
    Santos-Silva A; Charrua A; Cruz CD; Gharat L; Avelino A; Cruz F
    Auton Neurosci; 2012 Jan; 166(1-2):35-8. PubMed ID: 22037502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity.
    Apostolidis A; Jacques TS; Freeman A; Kalsi V; Popat R; Gonzales G; Datta SN; Ghazi-Noori S; Elneil S; Dasgupta P; Fowler CJ
    Eur Urol; 2008 Jun; 53(6):1245-53. PubMed ID: 18343564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A longitudinal study of sensory biomarkers of progression in patients with diabetic peripheral neuropathy using skin biopsies.
    Narayanaswamy H; Facer P; Misra VP; Timmers M; Byttebier G; Meert T; Anand P
    J Clin Neurosci; 2012 Nov; 19(11):1490-6. PubMed ID: 22705139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TRPV1, NK1 receptor and substance P immunoreactivity and gene expression in the rat lumbosacral spinal cord and urinary bladder after systemic, low dose vanilloid administration.
    Heng YJ; Saunders CI; Kunde DA; Geraghty DP
    Regul Pept; 2011 Apr; 167(2-3):250-8. PubMed ID: 21329730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravesical glucidic capsaicin versus glucidic solvent in neurogenic detrusor overactivity: a double blind controlled randomized study.
    de Sèze M; Gallien P; Denys P; Labat JJ; Serment G; Grise P; Salle JY; Blazejewski S; Hazane C; Moore N; Joseph PA
    Neurourol Urodyn; 2006; 25(7):752-7. PubMed ID: 16986136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New therapeutic options for refractory neurogenic detrusor overactivity.
    Giannantoni A; Mearini E; Di Stasi SM; Costantini E; Zucchi A; Mearini L; Fornetti P; Del Zingaro M; Navarra P; Porena M
    Minerva Urol Nefrol; 2004 Mar; 56(1):79-87. PubMed ID: 15195033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nerve fibres in urothelium and submucosa of neuropathic urinary bladder: an immunohistochemical study with S-100 and neurofilament.
    Vaidyanathan S; van Velzen D; Krishnan KR; Parsons KF; Soni BM; Woolfenden A; Fraser MH; Howard CV
    Paraplegia; 1996 Mar; 34(3):137-51. PubMed ID: 8668354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suburothelial myofibroblasts in the human overactive bladder and the effect of botulinum neurotoxin type A treatment.
    Roosen A; Datta SN; Chowdhury RA; Patel PM; Kalsi V; Elneil S; Dasgupta P; Kessler TM; Khan S; Panicker J; Fry CH; Brandner S; Fowler CJ; Apostolidis A
    Eur Urol; 2009 Jun; 55(6):1440-8. PubMed ID: 19054608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.